PDGFRB and Alzheimer disease: Similar to our results of the quantitative assessments of Aβ34 immunoreactivity, the percentage of PDGFR-β positive capillaries was significantly decreased in AD patients in comparison to non-demented controls both in cortex and hippocampus (Fig. 2g).